Our products are currently not available in your region.In the meantime, you can learn more about our research efforts, our scientific platform and all the latest news by visiting our main website.
The Moderna COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. The Moderna COVID-19 vaccine has been granted Emergency Use Authorization (EUA) for childr
Modernaon Tuesday asked the Food and Drug Administration for full U.S. approval of its Covid-19 vaccine — the second drugmaker in the U.S. to seek a biologics license that will allow it to market the shots directly to consumers. The mRNA vaccine is currently on the U.S. market under...
A screenshot taken on May 18, 2020, from the website of the U.S. biotech company Moderna shows an introduction of its work on a potential vaccine against the COVID-19. (Xinhua) The vaccine mRNA-1273 was generally safe and well tolerated, with a safety profile consistent with that seen...
Washington— U.S. biotechnology firm Moderna on Monday said lab studies showed its COVID-19 vaccine would remain protective against variants of thecoronavirusfirst identified in the United Kingdom and South Africa. But out of caution, the company will test adding a second booster of its va...
New CDC website shows if COVID or flu is on the rise in 2024 More In: Booster Dose COVID-19 Vaccine COVID-19 Vaccines Haley Ott Haley Ott is the CBS News Digital international reporter, based in the CBS News London bureau. TwitterInstagram...
To date, 98% of the target population in Fiji have received at least one dose of the COVID-19 vaccine and 66% are now fully vaccinated. This means 587,948 adults have received their first dose and 387,320 have received their second doses. ...
A week after granting an emergency-use authorization for the country’s first COVID-19 vaccine, US regulators have followed with a second: another RNA vaccine, this one made by Moderna of Cambridge, Massachusetts. The emergency-use authorization followed quickly after a panel of external advisers...
The European Medicines Agency (EMA) has recommended the Moderna COVID-19 jab for conditional marketing authorization, doubling the options in Europe's vaccine arsenal as criticism of a slow and bungled roll-out mounts. Shortly after the EMA's approval, the European Commission, the...
Moderna: searching for a second act after CovidPremiumcontent Despite progress on a flu jab, the biotech group will be lossmaking for the next three years September 13 2023 Moderna’s mRNA flu vaccine shows promising results Trial finds latest version elicited better immune response than existing...